市场调查报告书
商品编码
1438555
全球脑机介面 - 市场占有率分析、产业趋势与统计、成长预测(2024 - 2029)Global Brain-computer Interface - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2024 - 2029) |
※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。
预计2024年全球脑机介面市场规模将达20亿美元,预计2029年将达到32.5亿美元,在预测期间(2024-2029年)CAGR为10.29%。
由于製造和供应链活动的封锁和中断,COVID-19 对市场的最初影响是巨大的。然而,COVID-19 大流行加速了新技术的部署,同时也增加了最终用户对新技术的依赖。脑机介面(BCI)技术越来越多地用于治疗许多患有身体障碍的老年患者,将反映老年人意图的特定讯号特征转化为命令,使他们能够提高运动和认知能力,从而可以使用作为COVID-19 期间復健医学的一种有前景的工具,可能会对市场成长产生积极影响。根据 2021 年 9 月发布的报告《轮椅运动与控制中基于运动影像脑电图的脑机介面:系统文献回顾》,COVID-19 为开发和实施脑机介面、生物医学解决方案、辅助技术(AT ),以帮助严重残障人士参与日常生活。
此外,由于神经退化性疾病的盛行率不断增加、公司为改进脑机介面技术而进行的研发活动不断增加以及设备小型化等各种技术进步,脑机介面市场可能会快速成长。
在所有因素中,神经退化性疾病的盛行率不断增加是预计在预测期内推动脑机介面市场的最重要因素。根据帕金森基金会预测,2020年美国可能有超过93万人患有帕金森氏症。而且,该基金会的报告也预测,到2020年,帕金森氏症患者数量预计将增加至120万人。到2030年。这意味着自2010 年以来,帕金森病患病率预计将增加约1.8 倍,突显需要针对该患者群体优化护理和治疗策略,以减轻护理人员的护理负担并减轻医疗保健系统的经济负担。因此,大多数这些患者最终需要持续的护理和监测或帮助,这可以透过使用脑机介面设备来实现。
此外,各公司研发活动的增加以及政府对脑机介面技术开发和新应用的投资的增加是预测期内推动市场成长的主要因素。例如,根据2020 年8 月发表的一篇题为《脑机介面企业融资》的文章,澳洲联邦政府向名为Bionic Vision Australia 的研究财团提供了4,200 万美元的资助,用于开发仿生视觉技术,这是一种大脑-电脑介面技术。该技术后来转让给 Bionic Vision Technologies,该公司从私人资助者那里筹集了 1800 万美元,大概用于进一步的临床试验和进一步的开发。世界各地政府支持技术创新的投资正在增加,这将推动全球市场的成长。
然而,脑机介面设备的高成本和缺乏实施系统的专业知识是阻碍市场成长的主要因素。
从类型来看,非侵入性脑机介面领域预计将显着成长。由于该技术的高适用性和日益增加的神经系统疾病,非侵入性脑机介面领域被发现在整个市场中占据主导地位。基于脑电图的非侵入性脑机介面设备的开发有望提高BCI技术的主流可及性。此外,批准数量的成长预计也将补充市场的成长。例如,2021 年 4 月,美国食品药物管理局 (FDA) 批准使用脑机介面设备来帮助手部、手腕和手臂残疾的中风患者復原。 IpsiHand 上肢復健系统 (IpsiHand System) 由 Neurolutions 开发,使用非侵入性脑电图 (EEG) 电极(而不是植入大脑的更典型的电极)来记录大脑活动。
此外,与非侵入性脑机介面领域相关的研发活动和产品发布的增加也促进了市场的成长。例如,2020 年1 月,总部位于巴黎的脑机介面(BCI)新创公司NextMind 在CES 上推出了一款神经介面开发套件,售价400 美元。该设备是一种非侵入性脑电图(EEG ),是一种很好的神经介面开发工具包。- 建立了从颅骨外部测量神经元电压波动的方法。
因此,由于上述因素,预计该细分市场在预测期内将显着成长。
预计亚太地区脑机介面市场将在预测期内显着成长,特别是在日本和中国等发展中国家。该市场的特点是技术进步,预计将为医护人员和个人提供更好的选择。
此外,2020年,中国研究人员开发了基于忆阻器阵列的神经讯号分析系统,为高效脑机介面铺平了道路,并利用该系统实现了癫痫相关神经讯号的过滤和识别,达到了超过93 %。该系统借鉴了电子和医学研究领域研究人员的工作成果。预计这些发展将对亚太地区市场的成长产生正面影响。
此外,新技术涵盖了旨在彻底改变安全、自动化和通讯体验的广泛应用程式。例如,2021年,天津大学的一个神经工程团队正在研发第二代「BrainTalker」晶片,晶片功耗更低,系统单晶片整合度更高,研究人员报告指出:他们能够从脑电图讯号中捕获「高品质」的大脑意图,从而满足应用需求。
因此,由于上述因素,预计市场在预测期内将显着成长。
脑机介面市场竞争适中,拥有多元化的国际、区域和本地参与者。然而,一些大型国际企业,如 Natus Medical Incorporated、Compumedics Ltd、Emotive Incorporation、g.tec Medical Engineering GmbH 和 NeuroSky,凭藉其品牌形象和市场覆盖范围,在市场上占据主导地位。这些公司投资新技术,为客户提供数位化变革。
g.tec 医疗工程有限公司
The Global Brain-computer Interface Market size is estimated at USD 2 billion in 2024, and is expected to reach USD 3.25 billion by 2029, growing at a CAGR of 10.29% during the forecast period (2024-2029).
The initial impact of COVID-19 on the market was significant owing to lockdowns and disruptions in manufacturing and supply chain activities. However, the COVID-19 pandemic has hastened the deployment of new technologies while also increasing end users' reliance on them. The rising usage of brain-computer interface (BCI) technology for the treatment of many elderly patients suffering from physical impairments to translate specific signal features that reflect the elderly's intent into commands and enable them to improve their motor and cognitive abilities, which can be used as a promising tool in rehabilitation medicine during COVID-19, is likely to have a positive impact on the market growth. According to the report "Motor-Imagery EEG-Based BCIs in Wheelchair Movement and Control: A Systematic Literature Review" published in September 2021, the COVID-19 has created an opportunity for the development and implementation of innovative devices like BCIs, biomedical solutions, and assistive technologies (AT) to facilitate people with severe disabilities regarding their participation in daily life.
Further, the brain-computer interface market is likely to show rapid growth due to the increasing prevalence of neurodegenerative disorders, rising R&D activities by the companies to improve the brain-computer interface technology and various technological advancements such as miniaturization of devices.
Among all the factors, the increasing prevalence of neurodegenerative disorders is the foremost factor expected to drive the brain-computer interface market over the forecast period. According to the Parkinson's Foundation, more than 930,000 people in the United States were likely to be suffering from Parkinson's disease in 2020. Moreover, the report by the foundation also predicted that the number of people with Parkinson's disease is expected to rise to 1.2 million by 2030. This represents a projected increase of about 1.8 times in Parkinson's prevalence since 2010, highlighting the need for optimized care and treatment strategies for this patient population to diminish the burden of care on caregivers and ease the economic burden on the healthcare system. Therefore, most of these patients eventually require continuous care and monitoring or help, which can be facilitated by the use of brain-computer interface devices.
Moreover, the increase in R&D activities by various companies and investments from the governments in brain-computer interface technology development and new applications is a chief factor that may promote the growth of the market during the forecast period. For instance, according to an article titled "Funding for Brain-Computer Interface Ventures" published in August 2020, the Australian Federal Government awarded a USD 42 million grant to a research consortium called Bionic Vision Australia to develop bionic vision technology, a type of brain-computer interface technology. The technology was later transferred to Bionic Vision Technologies, which raised USD 18 million from private funders, presumably for further clinical trials and further development. Such investments by governments supporting technological innovation are increasing across the world, which will drive the market's growth globally.
However, the high cost of brain-computer interface devices and a lack of expertise in implementing the systems are the major factors hindering the market's growth.
By type, the non-invasive brain-computer interface segment is expected to witness significant growth. The non-invasive brain-computer interface segment is found to dominate the overall market owing to the high applicability of the technology and increasing neurological disorders. The development of non-invasive brain-computer interface devices based on EEG is expected to increase the mainstream accessibility of BCI technology. Moreover, growth in the number of approvals is also expected to supplement the market's growth. For instance, in April 2021, the United States Food and Drug Administration (FDA) approved the use of a brain-computer interface device to aid stroke patients with hand, wrist, and arm disabilities in their recovery. The IpsiHand Upper Extremity Rehabilitation System (IpsiHand System) was developed by Neurolutions and records brain activity using non-invasive electroencephalography (EEG) electrodes (rather than the more typical electrodes implanted into the brain).
Also, the increasing research and development activities and product launches pertaining to the non-invasive brain-computer interface segment are contributing to the market's growth. For instance, in January 2020, NextMind, a Paris-based brain-computer interface (BCI) startup, launched a neural interface dev kit at CES for USD 400. This device is a non-invasive electroencephalogram (EEG), which is a well-established method of measuring the voltage fluctuations of neurons from outside the skull.
Thus, due to the above-mentioned factors, the segment is expected to witness significant growth during the forecast period.
The Asia-Pacific brain-computer interface market is anticipated to grow significantly over the forecast period, particularly in developing countries such as Japan and China. The market is characterized by technological advancements that are expected to result in the availability of better options for healthcare personnel and individuals.
Furthermore, in 2020, Chinese researchers developed a neural signal analysis system with memristor arrays, paving the way for high-efficiency brain-machine interfaces, and used the system to implement the filtering and identification of epilepsy-related neural signals, achieving an accuracy of over 93%. The system draws upon work from researchers in the fields of electronics and medical research. Such developments are anticipated to have a positive impact on the growth of the market in the Asia-Pacific region.
Additionally, new technology encompasses a wide array of applications designed to revolutionize security, automation, and communication experiences. For instance, in 2021, a neuro-engineering team at Tianjin University was working on the research and development of the second-generation "BrainTalker" chip, which uses less power and offers higher system-on-chip integration, and the researchers reported that they were able to capture "good-quality" brain intentions from electroencephalogram signals that could satisfy application demands.
Thus, due to the above-mentioned factors, the market is expected to witness significant growth over the forecast period.
The brain-computer interface market is moderately competitive and has the presence of well-diversified international, regional, and local players. However, some big international players, such as Natus Medical Incorporated, Compumedics Ltd, Emotive Incorporation, g.tec medical engineering GmbH, and NeuroSky, dominate the market owing to their brand image and market reach. The companies are found investing in new technologies to provide a digital change to their customers.
g.tec medical engineering GmbH